Deutsche Bank’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Sell |
15,535
-3,969
| -20% | -$26.7K | ﹤0.01% | 3224 |
|
|
2025
Q1 | $176K | Sell |
19,504
-2,236
| -10% | -$20.2K | ﹤0.01% | 2987 |
|
|
2024
Q4 | $376K | Buy |
21,740
+7,757
| +55% | +$134K | ﹤0.01% | 2735 |
|
|
2024
Q3 | $223K | Buy |
13,983
+3,756
| +37% | +$60K | ﹤0.01% | 2839 |
|
|
2024
Q2 | $146K | Buy |
10,227
+118
| +1% | +$1.68K | ﹤0.01% | 2942 |
|
|
2024
Q1 | $143K | Buy |
10,109
+301
| +3% | +$4.27K | ﹤0.01% | 2965 |
|
|
2023
Q4 | $148K | Sell |
9,808
-230
| -2% | -$3.47K | ﹤0.01% | 2984 |
|
|
2023
Q3 | $159K | Buy |
10,038
+1,532
| +18% | +$24.2K | ﹤0.01% | 2899 |
|
|
2023
Q2 | $129K | Buy |
+8,506
| New | +$129K | ﹤0.01% | 3134 |
|
|
2022
Q2 | – | Sell |
-4,959
| Closed | -$47K | – | 4127 |
|
|
2022
Q1 | $47K | Sell |
4,959
-608
| -11% | -$5.76K | ﹤0.01% | 3776 |
|
|
2021
Q4 | $95K | Buy |
+5,567
| New | +$95K | ﹤0.01% | 3668 |
|